179 related articles for article (PubMed ID: 18651702)
1. L-Selectin-deficient SJL and C57BL/6 mice are not resistant to experimental autoimmune encephalomyelitis.
Uboldi C; Döring A; Alt C; Estess P; Siegelman M; Engelhardt B
Eur J Immunol; 2008 Aug; 38(8):2156-67. PubMed ID: 18651702
[TBL] [Abstract][Full Text] [Related]
2. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF
Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156
[TBL] [Abstract][Full Text] [Related]
3. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice.
Whitham RH; Jones RE; Hashim GA; Hoy CM; Wang RY; Vandenbark AA; Offner H
J Immunol; 1991 Dec; 147(11):3803-8. PubMed ID: 1719089
[TBL] [Abstract][Full Text] [Related]
4. Modulation of CD4 co-receptor limits spontaneous autoimmunity when high-affinity transgenic TCR specific for self-antigen is expressed on a genetically resistant background.
Illés Z; Waldner H; Reddy J; Anderson AC; Sobel RA; Kuchroo VK
Int Immunol; 2007 Oct; 19(10):1235-48. PubMed ID: 17804690
[TBL] [Abstract][Full Text] [Related]
5. Adoptive transfer of myelin basic protein-induced experimental autoimmune encephalomyelitis between SJL and B10.S mice: correlation of priming milieus with susceptibility and resistance phenotypes.
Chen F; Shaw MK; Li J; Lisak RP; Tse HY
J Neuroimmunol; 2006 Apr; 173(1-2):146-54. PubMed ID: 16480778
[TBL] [Abstract][Full Text] [Related]
6. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
[TBL] [Abstract][Full Text] [Related]
7. Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis.
Dittel BN; Merchant RM; Janeway CA
J Immunol; 1999 Jun; 162(11):6392-400. PubMed ID: 10352252
[TBL] [Abstract][Full Text] [Related]
8. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells.
Klein L; Klugmann M; Nave KA; Tuohy VK; Kyewski B
Nat Med; 2000 Jan; 6(1):56-61. PubMed ID: 10613824
[TBL] [Abstract][Full Text] [Related]
9. Myelin-reactive antibodies mediate the pathology of MBP-PLP fusion protein MP4-induced EAE.
Kuerten S; Pauly R; Rottlaender A; Rodi M; Gruppe TL; Addicks K; Tary-Lehmann M; Lehmann PV
Clin Immunol; 2011 Jul; 140(1):54-62. PubMed ID: 21489887
[TBL] [Abstract][Full Text] [Related]
10. Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL/J mice.
Stevens DB; Chen K; Seitz RS; Sercarz EE; Bronstein JM
J Immunol; 1999 Jun; 162(12):7501-9. PubMed ID: 10358205
[TBL] [Abstract][Full Text] [Related]
11. Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice.
Mangalam A; Rodriguez M; David C
Eur J Immunol; 2006 Dec; 36(12):3356-70. PubMed ID: 17125142
[TBL] [Abstract][Full Text] [Related]
12. MBP-PLP fusion protein-induced EAE in C57BL/6 mice.
Kuerten S; Lichtenegger FS; Faas S; Angelov DN; Tary-Lehmann M; Lehmann PV
J Neuroimmunol; 2006 Aug; 177(1-2):99-111. PubMed ID: 16781782
[TBL] [Abstract][Full Text] [Related]
13. Induction of experimental autoimmune encephalomyelitis in severe combined immunodeficient mice reconstituted with allogeneic or xenogeneic hematopoietic cells.
Jones RE; Bourdette DN; Whitham RH; Offner H; Vandenbark AA
J Immunol; 1993 May; 150(10):4620-9. PubMed ID: 8097758
[TBL] [Abstract][Full Text] [Related]
14. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
[TBL] [Abstract][Full Text] [Related]
15. Characterization of proteolipid protein-peptide-specific CD(4)(+) T cell of experimental allergic encephalomyelitis in Biozzi AB/H mice.
Peng Y; Liu CP
Chin Med J (Engl); 2002 Apr; 115(4):521-4. PubMed ID: 12133288
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE.
Xu B; Haviernik P; Wolfraim LA; Bunting KD; Scott DW
Mol Ther; 2006 Jan; 13(1):42-8. PubMed ID: 16219491
[TBL] [Abstract][Full Text] [Related]
17. IL-12 driven upregulation of P-selectin ligand on myelin-specific T cells is a critical step in an animal model of autoimmune demyelination.
Deshpande P; King IL; Segal BM
J Neuroimmunol; 2006 Apr; 173(1-2):35-44. PubMed ID: 16413063
[TBL] [Abstract][Full Text] [Related]
18. Active immunization with proteolipid protein (190-209) induces ascending paralysing experimental autoimmune encephalomyelitis in C3H/HeJ mice.
Göbel K; Bittner S; Ruck T; Budde T; Wischmeyer E; Döring F; Wiendl H; Meuth SG
J Immunol Methods; 2011 Mar; 367(1-2):27-32. PubMed ID: 21199659
[TBL] [Abstract][Full Text] [Related]
19. Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice.
Dittel BN; Urbania TH; Janeway CA
J Autoimmun; 2000 Jun; 14(4):311-8. PubMed ID: 10882057
[TBL] [Abstract][Full Text] [Related]
20. PSGL-1 is dispensible for the development of active experimental autoimmune encephalomyelitis in SJL/J mice.
Bill R; Döring A; Deutsch U; Engelhardt B
J Neuroimmunol; 2011 Mar; 232(1-2):207-8. PubMed ID: 21051092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
